Back to Depression And Anxiety
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03060096

NCT03060096
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are 18 years old or older
  • You have scored 10 or higher on the GAD-7 anxiety questionnaire and/or 8 or higher on the PHQ-9 depression questionnaire, suggesting significant anxiety or depression symptoms
  • You have a past history of treated Stage I, II, or III breast, colorectal, prostate, gynecologic (uterine or cervical), or non-Hodgkin's lymphoma cancer, whether newly diagnosed or as a recurrence
  • You finished your main cancer treatment (surgery, chemotherapy, and/or radiation) between 6 months and 5 years ago; being on ongoing maintenance or hormonal therapy is still acceptable
  • You currently live in one of these states: California, Georgia, Illinois, Kansas, Michigan, Minnesota, Missouri, New Mexico, North Carolina, North Dakota, South Carolina, Virginia, Tennessee, or Wisconsin
  • There is a trial-trained therapist available in the state where you live
  • You are able to speak and understand English
  • You have access to a telephone

Who may not be able to join:

  • You have seen a psychologist, counselor, or therapist regularly in the last 30 days
  • You have reported actively using alcohol or drugs in a harmful way within the last 30 days
  • Your prostate cancer or non-Hodgkin's lymphoma was managed only by monitoring (no surgery, chemotherapy, or radiation was ever used)
  • You have been diagnosed with a second, different cancer after your original cancer diagnosis (except for certain common skin cancers)
  • Your cancer is currently active or spreading (your cancer must be stable or showing no signs of disease)
  • You have been told by a healthcare provider that you have dementia
  • You have experienced symptoms of psychosis (such as hallucinations or losing touch with reality) in the last 30 days (confirm with trial site)
  • You are currently having active thoughts of suicide with a specific plan and intention to act on them
  • Your psychiatric medications have been changed or adjusted within the last 30 days
  • You have a level of hearing loss that would prevent you from taking part in telephone sessions, as assessed by the research team
  • You are unwilling or unable to provide the names and contact details of two family members or friends who can serve as emergency contacts during the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Wake Forest University Health Sciences
Registry
clinicaltrials_gov
Start date
19 July 2018
Est. completion
29 July 2022

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Study Intervention Measured by Retention; Feasibility of Study Intervention Measured by Adherence to Intervention; Feasibility of Study Intervention Measured by Recruitment Rate; Feasibility of Study Intervention Measured by Accrual Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov